Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001835268-25-000052
Filing Date
2025-08-13
Accepted
2025-08-13 09:04:38
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cntb-20250630.htm   iXBRL 10-Q 767666
2 EX-10.1 cntb-20250630ex101.htm EX-10.1 42937
3 EX-31.1 cntb-20250630ex311.htm EX-31.1 9951
4 EX-31.2 cntb-20250630ex312.htm EX-31.2 9991
5 EX-32.1 cntb-20250630ex321.htm EX-32.1 7146
  Complete submission text file 0001835268-25-000052.txt   4894821

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntb-20250630.xsd EX-101.SCH 31227
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntb-20250630_cal.xml EX-101.CAL 59520
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntb-20250630_def.xml EX-101.DEF 136149
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntb-20250630_lab.xml EX-101.LAB 477859
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntb-20250630_pre.xml EX-101.PRE 327817
69 EXTRACTED XBRL INSTANCE DOCUMENT cntb-20250630_htm.xml XML 615870
Mailing Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130
Business Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40212 | Film No.: 251209180
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)